# Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme

> **NCT00003464** · PHASE2 · COMPLETED · sponsor: **Duke University** · enrollment: 50 (estimated)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** temozolomide
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003464
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-09
- **Primary completion:** —
- **Final completion:** 2003-08
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2013-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003464, "Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*